
|Articles|May 8, 2018
The Missing Link in Amazon’s Healthcare Takeover
Author(s)Michelle Maskaly
John Cervione, managing partner of Blue Fin Group, talks briefly about Amazon’s foray into the healthcare and pharma industries.
Advertisement
John Cervione, managing partner of Blue Fin Group, talks briefly about Amazon’s foray into the healthcare and pharma industries, talks about what they are doing now, and the key element that is missing. His remarks come after a seminar at Asembia’s Specialty Pharmacy Summit in Las Vegas.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Ending the Pharma Relay Race with a Non-Opioid Breakthrough
2
How Do You Think Ai Can Improve FDA's Internal Process?
3
The Push at FDA to Tighten Oversight on DTC Prescription Drug Ads
4
Navigating Turbulent Markets: What Two Decades in Biotech Finance Taught Me About Building Companies That Last
5




